Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
ATEX Announces Phase V Exploration Plans
-
Intrepid Metals Appoints Ken Engquist as CEO
-
Phio Pharmaceuticals to Present at the H.C. Wainwright 26th Annual Global Investment Conference
-
Phonak + Advanced Bionics sponsor new family film, Rally Caps - Worldwide release on September 10th
-
Churchill Resources to Commence Drilling September 16 at Taylor Brook Magmatic Intrusive Complex; Large Tonnage Nickel Target added at Florence Lake
-
Mulvihill Capital Management Inc. Announces Ratios for Merger of Top 10 Split Trust into Premium Global Income Split Corp.
-
Marimaca Appoints Oscar Valenzuela as VP Project and Alexis Muñoz as VP Project Execution
-
Phillips Edison & Company Upgraded by Moody’s to ‘Baa2’ with Stable Outlook
-
Mobilicom Reports Financial Results for the Six Months Ended June 30, 2024; Revenues Up 232%
-
Phillips Edison & Company Upgraded by Moody’s to ‘Baa2’ with Stable Outlook
-
BIZCLIK MEDIA LAUNCHES SEPTEMBER EDITIONS OF TECHNOLOGY, AI & MOBILE MAGAZINES
-
Regeneron to Highlight Progress Across Its Differentiated Oncology Portfolio and Pipeline at WCLC and ESMO
-
RedHill's Talicia® Listed as First-Line Choice for H. pylori in New American College of Gastroenterology Guidelines
-
Siyata Mobile to Showcase PTT Solutions at EMS World Expo September 9 - 13
-
SystImmune, Inc. to Present New BL-B01D1 Data in Urothelial, Biliary Tract, and Esophageal Squamous Cell Carcinoma at ESMO Congress 2024
-
LogicSource and Cleveland Clinic Collaborate to Help Health Systems with Non-Clinical Procurement Practices and Benchmarking
-
MoonLake Immunotherapeutics to host a Capital Markets Update on Wednesday, September 11
-
Apogee Therapeutics Appoints Jeff S. Hartness as Chief Commercial Officer
-
G Mining Ventures Delivers PEA for High-Grade Oko West Gold Project in Guyana
-
Aurora Cannabis and Vectura Fertin Pharma, Inc. announce launch of novel Luo CBD lozenge
-
Compugen to Present at Single Cell Genomics 2024 Conference
-
ZIM Announces New Operational Cooperation with MSC Covering the Strategic Transpacific Trade
-
B. Riley Financial Provides Update on Strategic and Financing Initiatives
-
Veren Announces Strategic Infrastructure Transaction
-
Coppernico Provides Drilling Update on the Sombrero Project and Announces Participation in Upcoming Fall Conferences
-
FDA Issues 'Letter of Support' Encouraging Use of Synuclein-based Biomarker, αSyn-SAA, in Clinical Trials in Parkinson's and Related Diseases
-
Breaking the silence on menopause. More than half of women 40+ say they have experienced a change in the appearance of their teeth or gums as they age
-
Zentalis Pharmaceuticals to Present Preclinical Azenosertib Data at ESMO 2024
-
Gryphon Investors Closes Continuation Vehicle for Vessco Water
-
Freedom Holdings and The Awareness Group (TAG) Announce Binding LOI For Reverse Merger
-
Iris and Telycam Join Forces to Deliver Unprecedented Cloud-Based Camera Control
-
Canadian Medical Technology Consortium Collaborates on State-of-the-Art Postoperative Patient Management Platform, Led by FluidAI
-
FalconPoint Partners Appoints Adam Gross as Partner, Head of Business Development and Capital Markets
-
Cartesian Therapeutics Receives FDA Rare Pediatric Disease Designation for Descartes-08 for the Treatment of Juvenile Dermatomyositis
-
Aircastle Appoints David Odlum as Chief Risk Officer
-
Nanoscope Therapeutics Announces Presentations at the Retina Society and Advanced Therapies Europe Annual Meetings in Lisbon
-
Twin Oak ETF Company Introduces the Twin Oak Short Horizon Absolute Return ETF for Family Offices
-
TELYNET USA LLC: We Are Now Operating in the U.S. Market!
-
Dentalcorp to Participate at Upcoming Investor Conferences
-
BeiGene Announces Updates to Commercial Leadership Team
-
Velma-Alma School District Announces Partnership with Varsity Tutors for Schools to Provide Live and On-Demand Tutoring Resources for All Students
-
Enigma Biomedical - USA Announces Collaboration with Alamar Biosciences to Advance the Field of Diagnostics for Neurodegenerative Diseases
-
MY DR NOW Celebrates the Launch of New Primary Care Facility in Phoenix, AZ
-
Madison Dearborn Partners Completes Strategic Investment in Harmonia Holdings Group; Industry Veteran Damon Griggs joins Harmonia as CEO and Chairman
-
Lynk Announces Executive Realignment and Expansion of Leadership Team to Accelerate the Company’s Next Phase of Growth
-
Pembina Pipeline Corporation Announces Pembina Gas Infrastructure’s Agreement to Acquire Midstream Assets From Veren Inc.
-
Capco and ESG Announce Partnership to Improve CIS Delivery
-
Jeremiah Samples Appointed by West Virginia Lobbyist Group, Village Caregiving as Vice President of Government Affairs and Public Policy
-
PSG Announces Strategic Growth Investments in Education Technology Platforms Verity IQ and Campus Ivy
-
Novocure to Present Real-World Data at ESMO 2024 Demonstrating Improved Survival Outcomes for Newly Diagnosed Glioblastoma Patients with Increased Use of Tumor Treating Fields (TTFields) Therapy
